Terete Borrás, PhD

Dr. Terete Borrás is an ocular molecular biologist with an interest in gene therapy. She received her Master's degree in Biology from the University of Madrid, Spain and her Doctorate in Molecular Biology under a collaborative program of the University of Madrid and Purdue University in Indiana.

Dr. Borrás studied regulation of lens gene expression at the National Eye Institute and led her laboratory to the identification of the mutation responsible for hereditary cataracts in an animal model. Terete has directed the research division of an ophthalmic pharmaceutical company in Barcelona, Spain with an interest in glaucoma drugs.

Currently Dr. Borrás is a Professor of Ophthalmology at the University of North Carolina at Chapel Hill. Her research is mainly focused on the search for alternative, long-term treatments of glaucoma. She has pioneered new strategies for delivering genes to the human trabecular meshwork and identified several candidate genes with good potential to reduce intraocular pressure. Dr. Borrás' goals are to be able to provide the molecular basis onto which new efficient and safer gene/drugs for glaucoma could be developed.